Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_assertion type Assertion NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_head.
- NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_assertion description "[To investigate the mechanism(s) of resistance to the RAF-inhibitor vemurafenib, we conducted a comprehensive analysis of the genetic alterations occurring in metastatic lesions from a patient with a BRAF(V600E)-mutant cutaneous melanoma who, after a first response, underwent subsequent rechallenge with this drug.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_provenance.
- NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_assertion evidence source_evidence_literature NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_provenance.
- NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_assertion SIO_000772 23948972 NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_provenance.
- NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_assertion wasDerivedFrom befree-20150227 NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_provenance.
- NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_assertion wasGeneratedBy ECO_0000203 NP865231.RAUBrZXTvl_uzjW5zfz46ZZTZNgPKGwV8SQN_hERzk_v0130_provenance.